<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336687">
  <stage>Registered</stage>
  <submitdate>21/03/2011</submitdate>
  <approvaldate>28/03/2011</approvaldate>
  <actrnumber>ACTRN12611000324910</actrnumber>
  <trial_identification>
    <studytitle>Pilot study of gastric bypass surgery in non-obese individuals with type 2 diabetes</studytitle>
    <scientifictitle>Pilot study of gastric bypass surgery in non-obese individuals with type 2 diabetes</scientifictitle>
    <utrn>U1111-1120-2186</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Type 2 diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Modified gastric bypass operation performed by open laparotomy, under general anaesthetic. A small gastric pouch is created and joined directly to a Roux loop of jejunum, thus bypassing most of the stomach and the duodenum. Duration approx 3 hours.</interventions>
    <comparator>no control</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Resolution of diabetes as judged by absence of need for medication and fasting blood sugar and HbA1c less than 7.</outcome>
      <timepoint>12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Improvement in diabetes control as judged by improvemnt in HbA1c and /or less medication</outcome>
      <timepoint>1 month, 3 months, 6 months, 9 months. 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Improvement in insulin resistance, as judged by improvement in HOMA and/or hyperinsulinaemic euglycaemic clamp.</outcome>
      <timepoint>1 month, 3 months, 6 months, 9 months. 12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Type 2 diabetes &gt; 1 year duration
HbA1c &gt; 7.5 &lt; 11%
BMI &gt; 25 &lt;30
HOMA &gt; 4.0</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Poor risk for major surgery
major end-organ damage from diabetes
taking insulin
positive GAD or IA2 antibodies</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>12</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype />
    <primarysponsorname />
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>NZ Lottery Grants Board</fundingname>
      <fundingaddress>PO Box 805
Wellington 6140</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>The Wakefield Clinic</fundingname>
      <fundingaddress>Private Bag 7909
Wellington 6242</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Jeremy Krebs</othercollaboratorname>
      <othercollaboratoraddress>Dept of Medicine
Wellington Hospital
Riddiford St
Wellington 6242</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to determine if overweight but not obese individuals with type 2 diabetes population can experience resolution of diabetes by gastric bypass surgery in the same way as can be achieved in a severly obese group of type 2 diabetic individuals.</summary>
    <trialwebsite>No website</trialwebsite>
    <publication>Nil</publication>
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>22/04/2011</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Richard Stubbs</name>
      <address>The Wakefield Clinic
PB 7909
Wellington</address>
      <phone>6443818100 Ext 5416</phone>
      <fax />
      <email>rsstubbs@wakefieldclinic.co.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Richard Stubbs</name>
      <address>The Wakefield Clinic
PB 7909
Wellington</address>
      <phone>6443818100 Ext 5416</phone>
      <fax />
      <email>rsstubbs@wakefieldclinic.co.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Richard Stubbs</name>
      <address>The Wakefield Clinic
PB 7909
Wellington</address>
      <phone />
      <fax />
      <email />
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>